NIH director hails speed of potential vaccine development

Dr. Francis Collins said he believes most Americans will have access to a vaccine by next spring.

• Jul 23, 2020

Trump touts COVID-19 vaccine research

President Trump tried to paint an optimistic picture of the country's fight against the coronavirus during a White House briefing on Wednesday. Mr. Trump claimed that the U.S. is doing "tremendously well" on therapeutic research and vaccines, and added it would be "great" if a cure was eventually found. Watch his remarks.

• Jul 22, 2020
• 00:54

Multiple COVID-19 vaccine doses may be necessary, Bill Gates says

"None of the vaccines at this point appear like they'll work with a single dose," Gates said.

• Jul 23, 2020

Moderna advances potential COVID-19 vaccine

As states continue to shatter daily records for new coronavirus cases, Moderna said it's moving forward with a potential vaccine. Dr. James Curran, dean of Emory University's Rollins School of Public Health, joins CBSN's Tanya Rivero to discuss the news surrounding the potential vaccine and the Trump administration's order for hospitals to bypass reporting information to the CDC.

• Jul 15, 2020
• 03:48

Bill Gates on "serious mistakes" in COVID response

Microsoft co-founder and philanthropist Bill Gates said Wednesday that the U.S. has made "serious mistakes" in its response to the coronavirus pandemic. Gates urged the country to ramp up its testing capacity, and in an interview with "CBS Evening News" anchor and managing editor Norah O'Donnell, he also discussed progress toward a vaccine and the challenges of safely reopening schools.

• Jul 22, 2020
• 28:30

Moderna's vaccine triggers immune response

The first coronavirus vaccine tested in humans in the U.S. triggered an immune response and is moving to Phase 3 trials. Dr. David Agus explains what this means for the fight against the virus.

• Jul 15, 2020
• 05:30

Pfizer to provide U.S. with 100 million COVID-19 vaccine doses

U.S. government will pay pharmaceutical firms almost $2 billion, with a pledge to provide the vaccines for free.

• Jul 22, 2020

U.S. charges Chinese hackers with targeting vaccine research

The Department of Justice on Tuesday indicted two Chinese nationals who are accused of targeting COVID-19 research. Officials say the defendants never obtained any research, but face 11 charges including trade secret theft and wire fraud conspiracy. CBS News senior investigative correspondent Catherine Herridge joins CBSN's Errol Barnett with the latest.

• Jul 21, 2020
• 07:48

Feds charge Chinese cyber hackers who targeted COVID-19 research

The two hackers also allegedly stole millions of dollars' worth of trade secrets and private business information.

• Jul 21, 2020

School reopenings may trigger outbreaks

Coronavirus cases are on the rise in dozens of states even as schools prepare to reopen for the fall. CBS News' Laura Podesta reports on the latest developments, and pediatrician Dr. Dyan Hes joins CBSN to discuss a new study out of South Korea that suggests school reopenings will trigger more outbreaks, plus the likelihood of pregnant women passing the virus to their babies.

• Jul 21, 2020
• 13:02

Moderna CEO hiked his stock sales after vaccine news announced

Changes to executive stock-sale plans in May allowed hot biotech's top two leaders to cash out an extra $4 million in July.

• Jul 21, 2020

Oxford COVID vaccine trial results called "extremely encouraging"

AstraZeneca says the trial data "increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale."

• Jul 21, 2020

Hackers with "direct link" to Russian state targeting vaccine work

"These aren't common criminals," former U.K. spy agency chief says of "Cosy Bear" hackers accused of going after COVID-19 research.

• Jul 20, 2020

Russian hackers accused of targeting vaccine

A Russian-backed hacking group is believed to have targeted organizations working on a coronavirus vaccine. CBS News foreign correspondent Charlie D'Agata reports from London, where the world's leading clinical trials might be at risk, and CBS News senior investigative correspondent Catherine Herridge joined CBSN to discuss.

• Jul 17, 2020
• 06:42

U.S. again shatters new COVID case record

As labs struggle to keep up with growing testing demands and battles intensify over face-covering mandates and school-reopening plans, the U.S. has once again shattered its record of new coronavirus infections. CBS News' Naomi Ruchim reports on the latest developments, and Dr. Bob Lahita joined CBSN to discuss a new push to reduce what one U.S. official called "unnecessary" testing for COVID-19.

• Jul 17, 2020
• 12:32

Russia-backed hackers target COVID-19 vaccine

British and American intelligence officials said prominent hacking group APT29, responsible for hacking DNC servers in 2016, has targeted coronavirus vaccine-related work. CBS foreign correspondent Charlie D'Agata reports on the intelligence community's response and the rising security risks during the pandemic.

• Jul 17, 2020
• 02:01

U.S., U.K. and Canada say Russian hackers are targeting COVID vaccine research

The three countries warned that the group known as APT29 — also referred to as "the Dukes" or "Cozy Bear" — was behind the attacks.

• Jul 16, 2020

First coronavirus vaccine tested in U.S. moves forward

Nearly two dozen possible COVID-19 vaccines are in various stages of testing around the world. Candidates from China and Britain's Oxford University also are entering final testing stages.

• Jul 15, 2020

COVID-19 data being shifted away from CDC

Coronavirus cases, hospitalizations, and deaths continue to rise across parts of the U.S. CBS News' Laura Podesta reports on the latest, and Dr. Neeta Ogden joins CBSN to discuss concerns about a new order from the White House that shifts control of data on COVID-19 to the Department of Health and Human Services instead of the CDC.

• Jul 15, 2020
• 11:36

Facebook boycott leaders slam Zuckerberg

Civil rights leaders say that Facebook isn't doing enough to stop the spread of hate speech on its platform. Imran Ahmed, the founder and CEO of the Center for Countering Digital Hate, joins CBSN to discuss how big tech companies are profiting from misinformation.

• Jul 8, 2020
• 08:20

"Explosively large" surge in COVID cases

Novavax is the latest company to get $1.6 billion in federal funding to develop and distribute a coronavirus vaccine by early 2021. This comes as cases surge in states like Texas and Florida. Internal medicine specialist, Dr. Neeta Ogden joins CBSN to discuss the latest details

• Jul 8, 2020
• 08:43

U.S. commits $1.6 billion to Novavax coronavirus vaccine

The funding for the coronavirus vaccine candidate being developed by Novavax comes as part of Operation Warp Speed.

• Jul 7, 2020

Non-government experts could pick who gets COVID-19 vaccine first

The National Institutes of Health director said "people are a little uneasy about the government calling the shots here"

• Jul 3, 2020

Pfizer shows promise in vaccine trial

Pfizer and BioNTech reported encouraging signs in early clinical trials of a possible COVID-19 vaccine. The small study triggered stronger immune responses in recipients. More than 15 different possible vaccines are being tested on people worldwide. Dr. David Agus joined "CBS This Morning" with the latest on the global vaccine effort.

• Jul 2, 2020
• 02:55

Study: Protests did not lead to COVID spike

New research suggests the massive Black Lives Matter protests across the country have not led to a jump in coronavirus cases. Dr. Ron Elfenbein joined CBSN to discuss why researchers believe the there's been no surge tied to large groups of demonstrators, even while cases spike in a number of states that reopened early.

• Jun 29, 2020
• 10:56

Show More